Results 61 to 70 of about 1,109,304 (99)

Drug-Drug Interaction Liabilities with BTK Inhibitor TL-895. [PDF]

Cancer Res Commun
Stromatt JC, Ahmed EA, Drabison T, Nepal MR, Chowdhury AT, Orwick SJ, Buelow DR, Eisenmann ED, Huang KM, Sparreboom A, Baker SD.   +10 more
europepmc   +1 more source

Machine learning models for drug-drug interaction prediction from computational discovery to clinical application. [PDF]

NPJ Digit Med
Lu Y, Chen J, Fan N, Song W, Sheng H, Yang Y, Wang J.   +6 more
europepmc   +1 more source

Contrastive learning-based multi-mechanism disentangled assessment for drug-drug interaction. [PDF]

BMC Bioinformatics
Zhang J, Zeng Y, Tang C, Zhong C, Wen H, Liu Y.   +5 more
europepmc   +1 more source

UGT2B7-mediated drug-drug interaction between cannabinoids and hydromorphone. [PDF]

Drug Metab Dispos
Coates S, Bardhi K, Zhao M, Lazarus P.
europepmc   +1 more source

A Dose-Aware Model for Revealing Dose-Risk Relationship of Drug-Drug Interaction. [PDF]

CPT Pharmacometrics Syst Pharmacol
Shi Y, Sun A, Yang Y, Nan H, Xu J, Shan M, Eadon MT, Su J, Zhang P.   +8 more
europepmc   +1 more source

MHAFR-DDI: a multimodal hierarchical attention fusion and relation-aware architecture for drug-drug interaction event prediction. [PDF]

Brief Bioinform
Li M, Cao C, Zou Q, Wei L, Wang Y.
europepmc   +1 more source

Drug-Drug Interaction Management Among Pharmacists in Jordan: A National Comparative Survey. [PDF]

Pharmacy (Basel)
Abdel-Qader DH, Al-Kubaisi KA, Taybeh E, Al Mazrouei N, Ibrahim R, Albassam A.   +5 more
europepmc   +1 more source

DDI-CYP: Metabolism ensemble models for drug-drug interaction predictions. [PDF]

Drug Metab Dispos
Wong JT, Harris JS, Lane TR, Urbina F, Ekins S.   +4 more
europepmc   +1 more source

Graph former-CL: A novel graph transformer with contrastive learning framework for enhanced drug-drug interaction prediction. [PDF]

PLoS One
Amiri M, Zare O.
europepmc   +1 more source

Evaluation of Drug-Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the CYP3A4 Inhibitor Itraconazole: A Phase 1 Study in Healthy Participants. [PDF]

Clin Transl Sci
Luckey A, Larson KB, Rayad N, Heep M, Delhomme S, Kornmann G, Mueller JP, O'Donnell JP, O'Brien S, Fuhr R, Gillon JY.   +10 more
europepmc   +1 more source